Abstract
Background:
Recombinant human growth hormone (rhGH) replacement therapy is usually stopped after linear growth completion in patients with growth hormone deficiency. In patients with multiple pituitary hormone deficiency (MPHD), the long-term effects of discontinuation of rhGH replacement are unknown.
Methods:
In this study, the anthropometric and metabolic parameters of 24 male patients with adult growth hormone deficiency (AGHD) due to MPHD in childhood after cessation of rhGH therapy for a mean of 7.1 years were measured and compared with 35 age-matched controls. Body composition was evaluated by bioelectrical impedance analysis (BIA).
Results:
In the AGHD group, body mass index (BMI) was significantly increased and 29.2% had obesity. The AGHD group had a 17.7 cm increase in waist circumference (WC). The fat free mass (FFM) was significantly lower in the AGHD group. Both the fat mass (FM) and percentage of fat mass (FM%) were significantly increased in the AGHD group. Both the systolic blood pressure (BP) and diastolic pressure were significantly lower in AGHD group. The lipid profile was generally similar in both groups, except for a decrease of high density lipoprotein-cholesterol (HDL-C) in the AGHD group. There was significant hyperuricemia in the AGHD group.
Conclusions:
Cessation of rhGH leads to a significant increase of FM in early adulthood in male patients with childhood-onset MPHD (CO-MPHD).
Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
Research funding: This work was supported by the National Science Foundation of China (No. 81400774), PUMCH Youth Fund (No. 3332016128) and the fundamental research funds for central public welfare research institutes (No. 2017PT31004).
Employment or leadership: None declared.
Honorarium: None declared.
Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.
References
1. Molitch ME, Clemmons DR, Malozowski S, Merriam GR, Shalet SM, et al. Evaluation and treatment of adult growth hormone deficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2006;91:1621–34.10.1210/jc.2005-2227Search in Google Scholar
2. Uzunova I, Kirilov G, Zacharieva S, Shinkov A, Borissova AM, et al. Individual risk factors of the metabolic syndrome in adult patients with growth hormone deficiency – a cross-sectional case-control study. Exp Clin Endocrinol Diabetes 2015;123:39–43.10.1055/s-0034-1390460Search in Google Scholar
3. Berberoglu M, Siklar Z, Darendeliler F, Poyrazoglu S, Darcan S, et al. Evaluation of permanent growth hormone deficiency (GHD) in young adults with childhood onset GHD: a multicenter study. J Clin Res Pediatr Endocrinol 2008;1:30–7.10.4008/jcrpe.v1i1.7Search in Google Scholar
4. Bandgar TR, Prashanth M, Joshi SR, Menon PS, Shah NS. Characterization of adult onset growth hormone deficiency syndrome in patients with hypothalamopituitary diseases: Asian Indian data. J Postgrad Med 2008;54:110–4.10.4103/0022-3859.40777Search in Google Scholar
5. Yang HB, Zhang MQ, Pan H, Zhu HJ. Management of adult growth hormone deficiency at Peking Union Medical College Hospital: a survey among physicians. Chin Med Sci J 2016;31:168–72.10.1016/S1001-9294(16)30046-3Search in Google Scholar
6. Yang H, Zhu H, Yan K, Pan H. Childhood-onset adult growth hormone deficiency: clinical, hormonal, and radiological assessment in a single center in China. Horm Res Paediatr 2017;88:155–9.10.1159/000478527Search in Google Scholar
7. Shimatsu A, Tai S, Tanaka T, Fujieda K, Teramoto A, et al. Clinical characteristics of Japanese adults with growth hormone deficiency: a HypoCCS database study. Endocr J 2011;58:325–33.10.1507/endocrj.K10E-363Search in Google Scholar
8. Veldhuis JD, Roemmich JN, Richmond EJ, Rogol AD, Lovejoy JC, et al. Endocrine control of body composition in infancy, childhood, and puberty. Endocr Rev 2005;26:114–46.10.1210/er.2003-0038Search in Google Scholar
9. Attanasio AF, Howell S, Bates PC, Frewer P, Chipman J, et al. Body composition, IGF-I and IGFBP-3 concentrations as outcome measures in severely GH-deficient (GHD) patients after childhood GH treatment: a comparison with adult onset GHD patients. J Clin Endocrinol Metab 2002;87:3368–72.10.1210/jcem.87.7.8593Search in Google Scholar
10. Zimmet P, M M Alberti KG, Serrano Rios M. A new international diabetes federation worldwide definition of the metabolic syndrome: the rationale and the results. Rev Esp Cardiol 2005;58:1371–6.10.1016/S1885-5857(06)60742-1Search in Google Scholar
11. Gotherstrom G, Svensson J, Koranyi J, Alpsten M, Bosaeus I, et al. A prospective study of 5 years of GH replacement therapy in GH-deficient adults: sustained effects on body composition, bone mass, and metabolic indices. J Clin Endocrinol Metab 2001;86:4657–65.10.1210/jcem.86.10.7887Search in Google Scholar
12. Svensson J, Fowelin J, Landin K, Bengtsson BA, Johansson JO. Effects of seven years of GH-replacement therapy on insulin sensitivity in GH-deficient adults. J Clin Endocrinol Metab 2002;87:2121–7.10.1210/jcem.87.5.8482Search in Google Scholar
13. Florakis D, Hung V, Kaltsas G, Coyte D, Jenkins PJ, et al. Sustained reduction in circulating cholesterol in adult hypopituitary patients given low dose titrated growth hormone replacement therapy: a two year study. Clin Endocrinol 2000;53:453–9.10.1046/j.1365-2265.2000.01108.xSearch in Google Scholar
14. O’Neal DN, Hew FL, Best JD, Alford F. The effect of 24 months recombinant human growth hormone (rh-GH) on LDL cholesterol, triglyceride-rich lipoproteins and apo [a] in hypopituitary adults previously treated with conventional replacement therapy. Growth Horm IGF Res 1999;9:165–73.10.1054/ghir.1999.0102Search in Google Scholar
15. Attanasio AF, Shavrikova E, Blum WF, Cromer M, Child CJ, et al. Continued growth hormone (GH) treatment after final height is necessary to complete somatic development in childhood-onset GH-deficient patients. J Clin Endocrinol Metab 2004;89:4857–62.10.1210/jc.2004-0551Search in Google Scholar
16. Albu JB, Kovera AJ, Johnson JA. Fat distribution and health in obesity. Ann N Y Acad Sci 2000;904:491–501.10.1111/j.1749-6632.2000.tb06505.xSearch in Google Scholar
17. Johannsson G, Albertsson-Wikland K, Bengtsson BA. Discontinuation of growth hormone (GH) treatment: metabolic effects in GH-deficient and GH-sufficient adolescent patients compared with control subjects. Swedish Study Group for Growth Hormone Treatment in Children. J Clin Endocrinol Metab 1999;84:4516–24.Search in Google Scholar
18. Vahl N, Juul A, Jorgensen JO, Orskov H, Skakkebaek NE, et al. Continuation of growth hormone (GH) replacement in GH-deficient patients during transition from childhood to adulthood: a two-year placebo-controlled study. J Clin Endocrinol Metab 2000;85:1874–81.10.1210/jcem.85.5.6598Search in Google Scholar
19. van der Klaauw AA, Biermasz NR, Feskens EJ, Bos MB, Smit JW, et al. The prevalence of the metabolic syndrome is increased in patients with GH deficiency, irrespective of long-term substitution with recombinant human GH. Eur J Endocrinol 2007;156:455–62.10.1530/EJE-06-0699Search in Google Scholar
20. Chan L, Xue H, Xiaoya Z, Jiajia X, Wei R, et al. Lipid accumulation product: a simple and accurate index for predicting metabolic syndrome in patients with adult growth hormone deficiency. Exp Clin Endocrinol Diabetes 2016;124:220–4.10.1055/s-0035-1569402Search in Google Scholar
21. Sun G, French CR, Martin GR, Younghusband B, Green RC, et al. Comparison of multifrequency bioelectrical impedance analysis with dual-energy X-ray absorptiometry for assessment of percentage body fat in a large, healthy population. Am J Clin Nutr 2005;81:74–8.10.1093/ajcn/81.1.74Search in Google Scholar
22. Bolanowski M, Nilsson BE. Assessment of human body composition using dual-energy x-ray absorptiometry and bioelectrical impedance analysis. Med Sci Monit 2001;7:1029–33.Search in Google Scholar
©2018 Walter de Gruyter GmbH, Berlin/Boston